Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement.

International journal of immunopathology and pharmacology - 1 Jan 2000

Falcone C, Emanuele E, Buzzi M P, Ballerini L, Repetto A, Canosi U, Mazzucchelli I, Schirinzi S, Sbarsi I, Boiocchi C, Cuccia M

Abstract excerpt

Upregulation of the receptor for advanced glycation end products (RAGE) may play a crucial role in neointimal formation upon vessel injury. The -374T/A variant of the RAGE gene promoter, which has been associated with an altered expression of the cell-surface receptor, could exert a protective ef...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angioplasty, Balloon, Coronary
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Restenosis

Share to Data Interpretation, Statistical

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Share to Sex Characteristics

Share to Stents

Source

Identifiers

PMID: 18179750
DOI: 10.1177/039463200702000413

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18179750-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement.PMID 18179750Read ↗

-374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis.Semantic proximity Read ↗

Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease.Semantic proximity Read ↗

Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.Semantic proximity Read ↗

Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients.Semantic proximity Read ↗

Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated?Semantic proximity Read ↗

Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.Semantic proximity Read ↗

The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.Semantic proximity Read ↗

The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.Semantic proximity Read ↗

Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.Semantic proximity Read ↗

The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis.Semantic proximity Read ↗

5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.Semantic proximity Read ↗

Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.